217 related articles for article (PubMed ID: 9011069)
41. Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice.
Curfs JH; van der Meide PH; Billiau A; Meuwissen JH; Eling WM
Exp Parasitol; 1993 Sep; 77(2):212-23. PubMed ID: 8375490
[TBL] [Abstract][Full Text] [Related]
42. T-lymphocytes response persists following Plasmodium berghei strain Anka infection resolution and may contribute to later experimental cerebral malaria outcomes.
de Miranda AS; Ferreira RN; Vieira ÉLM; Abreu LKS; Brant F; Vieira LB; Ribeiro FM; Machado FS; Rachid MA; Teixeira AL
J Neuroimmunol; 2019 May; 330():5-11. PubMed ID: 30763800
[TBL] [Abstract][Full Text] [Related]
43. Early cytokine production is associated with protection from murine cerebral malaria.
Mitchell AJ; Hansen AM; Hee L; Ball HJ; Potter SM; Walker JC; Hunt NH
Infect Immun; 2005 Sep; 73(9):5645-53. PubMed ID: 16113282
[TBL] [Abstract][Full Text] [Related]
44. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria.
Ohayon A; Golenser J; Sinay R; Tamir A; Altman A; Pollack Y; Isakov N
Infect Immun; 2010 Oct; 78(10):4195-205. PubMed ID: 20660606
[TBL] [Abstract][Full Text] [Related]
45. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
[TBL] [Abstract][Full Text] [Related]
46. IFNAR1 controls progression to cerebral malaria in children and CD8+ T cell brain pathology in Plasmodium berghei-infected mice.
Ball EA; Sambo MR; Martins M; Trovoada MJ; Benchimol C; Costa J; Antunes Gonçalves L; Coutinho A; Penha-Gonçalves C
J Immunol; 2013 May; 190(10):5118-27. PubMed ID: 23585679
[TBL] [Abstract][Full Text] [Related]
47. Immunization against cerebral pathology in Plasmodium berghei-infected mice.
Curfs JH; Hermsen CC; Meuwissen JH; Eling WM
Parasitology; 1992 Aug; 105 ( Pt 1)():7-14. PubMed ID: 1437278
[TBL] [Abstract][Full Text] [Related]
48. Comparison of CD8
Barrera V; Haley MJ; Strangward P; Attree E; Kamiza S; Seydel KB; Taylor TE; Milner DA; Craig AG; Couper KN
Front Immunol; 2019; 10():1747. PubMed ID: 31396236
[TBL] [Abstract][Full Text] [Related]
49. High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology.
Haque A; Best SE; Amante FH; Ammerdorffer A; de Labastida F; Pereira T; Ramm GA; Engwerda CR
Infect Immun; 2011 May; 79(5):1882-8. PubMed ID: 21343349
[TBL] [Abstract][Full Text] [Related]
50. Attenuated T Cell Responses Are Associated With the Blockade of Cerebral Malaria Development by YOP1-Deficient
Hai L; Shi X; Wang Q
Front Immunol; 2021; 12():642585. PubMed ID: 34025654
[TBL] [Abstract][Full Text] [Related]
51. Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities.
Randall LM; Amante FH; McSweeney KA; Zhou Y; Stanley AC; Haque A; Jones MK; Hill GR; Boyle GM; Engwerda CR
Infect Immun; 2008 Jul; 76(7):3312-20. PubMed ID: 18474652
[TBL] [Abstract][Full Text] [Related]
52. Filaria-induced IL-10 suppresses murine cerebral malaria.
Specht S; Ruiz DF; Dubben B; Deininger S; Hoerauf A
Microbes Infect; 2010 Aug; 12(8-9):635-42. PubMed ID: 20420933
[TBL] [Abstract][Full Text] [Related]
53. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
[TBL] [Abstract][Full Text] [Related]
54. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
Settles EW; Moser LA; Harris TH; Knoll LJ
Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
[TBL] [Abstract][Full Text] [Related]
55. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
Randall LM; Amante FH; Zhou Y; Stanley AC; Haque A; Rivera F; Pfeffer K; Scheu S; Hill GR; Tamada K; Engwerda CR
J Immunol; 2008 Dec; 181(11):7458-62. PubMed ID: 19017933
[TBL] [Abstract][Full Text] [Related]
56. Protein Tyrosine Phosphatase Inhibition Prevents Experimental Cerebral Malaria by Precluding CXCR3 Expression on T Cells.
Van Den Ham KM; Smith LK; Richer MJ; Olivier M
Sci Rep; 2017 Jul; 7(1):5478. PubMed ID: 28710387
[TBL] [Abstract][Full Text] [Related]
57. Regulatory CD4+ CD25+ Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria.
Vigário AM; Gorgette O; Dujardin HC; Cruz T; Cazenave PA; Six A; Bandeira A; Pied S
Int J Parasitol; 2007 Jul; 37(8-9):963-73. PubMed ID: 17350019
[TBL] [Abstract][Full Text] [Related]
58. Protein kinase C-theta is required for development of experimental cerebral malaria.
Fauconnier M; Bourigault ML; Meme S; Szeremeta F; Palomo J; Danneels A; Charron S; Fick L; Jacobs M; Beloeil JC; Ryffel B; Quesniaux VF
Am J Pathol; 2011 Jan; 178(1):212-21. PubMed ID: 21224058
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus prevents murine cerebral malaria.
Bao LQ; Nhi DM; Huy NT; Hamano S; Hirayama K
Immunology; 2017 Feb; 150(2):155-161. PubMed ID: 27546479
[TBL] [Abstract][Full Text] [Related]
60. Protection from experimental cerebral malaria with a single intravenous or subcutaneous whole-parasite immunization.
Heiss K; Maier MI; Hoffmann A; Frank R; Bendszus M; Mueller AK; Pfeil J
Sci Rep; 2018 Feb; 8(1):3085. PubMed ID: 29449638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
